Anti–Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct

Anti–Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct–Ligated Mice

Published:2023-01 Issue:1 Volume:193 Page:11-26
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Gee Lucy M.V.,Barron-Millar Ben,Leslie Jack,Richardson Claire,Zaki Marco Y.W.^ORCID,Luli Saimir,Burgoyne Rachel A.,Cameron Rainie I.T.,Smith Graham R.^ORCID,Brain John G.,Innes Barbara,Jopson Laura,Dyson Jessica K.,McKay Katherine R.C.,Pechlivanis Alexandros,Holmes Elaine^ORCID,Berlinguer-Palmini Rolando^ORCID,Victorelli Stella,Mells George F.,Sandford Richard N.^ORCID,Palmer Jeremy^ORCID,Kirby John A.,Kiourtis Christos^ORCID,Mokochinski Joao,Hall Zoe^ORCID,Bird Thomas G.,Borthwick Lee A.,Morris Christopher M.^ORCID,Hanson Peter S.,Jurk Diana^ORCID,Stoll Elizabeth A.^ORCID,LeBeau Fiona E.N.,Jones David E.J.,Oakley Fiona^ORCID

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference61 articles.

1. Novel therapeutic targets in primary biliary cirrhosis;Dyson;Nat Rev Gastroenterol Hepatol,2015

2. Unmet clinical need in autoimmune liver diseases;Dyson;J Hepatol,2015

3. Effects of primary biliary cholangitis on quality of life and health care costs in the United Kingdom;Rice;Clin Gastroenterol Hepatol,2021

4. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis;Nevens;N Engl J Med,2016

5. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis;J Hepatol,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NR1H4 ameliorates Parkinson’s disease via inhibiting astrocyte activation and neuroinflammation in a CEBPβ/NF-κB dependent manner;International Immunopharmacology;2024-12

2. Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progression;JHEP Reports;2024-10

4. A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement;Life Medicine;2024-01-30

5. The Pathophysiology of Hepatic Encephalopathy at the Level of Gut-Liver-Brain Axis: The Role of Resident Innate Immune Cells;Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management;2024-01-15